Requadt Scott
Insider CIK 1664852 · EPIX Director · FTSV 10% owner · AVRO Director · ETTX 10% owner · TALS Chief Executive Officer, Director · VBIV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EPIX ESSA Pharma Inc. | D To issuer | 2025-10-09 | 2025-10-15 | 30,002 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2024-03-25 | 2024-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EPIX ESSA Pharma Inc. | J Other | 2023-11-06 | 2024-01-16 | 12,500 | — | $0 | 30,002 | SEC↗ |
| EPIX ESSA Pharma Inc. | J Other | 2023-10-30 | 2024-01-16 | 17,502 | — | $0 | 42,502 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | F Tax w/h | 2023-07-03 | 2023-07-06 | 11,786 | $3.08 | $36.3K | 578,403 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 320,000 | — | $0 | 320,000 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 320,000 | — | $0 | 320,000 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award | 2022-12-30 | 2023-02-03 | 4 | $0.87 | $3 | 590,193 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award | 2022-09-10 | 2022-09-13 | 80,000 | — | $0 | 590,189 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2022-07-29 | 2022-08-02 | 39,382 | $4.25 | $167.4K | 508,680 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2022-07-28 | 2022-07-28 | 3,090 | $4.25 | $13.1K | 469,298 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2022-07-26 | 2022-07-28 | 5,528 | $4.24 | $23.4K | 466,208 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2022-07-22 | 2022-07-26 | 9,444 | $3.75 | $35.4K | 460,680 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2022-06-29 | 2022-11-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-02 | 500,000 | — | $0 | 500,000 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award | 2021-12-31 | 2022-02-02 | 1,470 | $13.00 | $19.1K | 451,236 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2020-12-11 | 2021-01-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2020-12-11 | 2021-01-26 | 16,500 | — | $0 | 16,500 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2019-01-31 | 2019-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 6,702,213 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 8,552,024 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,500,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 361,829 | — | $0 | 361,829 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 453,395 | $15.00 | $6.80M | 1,623,405 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 412,583 | — | $0 | 1,170,010 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 323,341 | — | $0 | 685,170 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 755,780 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 938,489 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 1,922,682 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 1,922,682 | — | $0 | 3,616,951 | SEC↗ |
| FTSV Forty Seven, Inc. | P Buy | 2018-07-02 | 2018-07-02 | 200,000 | $16.00 | $3.20M | 3,816,951 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 938,489 | — | $0 | 938,489 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 755,780 | — | $0 | 1,694,269 | SEC↗ |
| AVRO AVROBIO, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-25 | 2,805,179 | — | $0 | 0 | SEC↗ |
| AVRO AVROBIO, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-25 | 9,435,150 | — | $0 | 0 | SEC↗ |
| AVRO AVROBIO, Inc. | C Conversion | 2018-06-25 | 2018-06-25 | 678,891 | — | $0 | 2,962,325 | SEC↗ |
| AVRO AVROBIO, Inc. | C Conversion | 2018-06-25 | 2018-06-25 | 2,283,434 | — | $0 | 2,283,434 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise deriv | 2018-06-14 | 2018-06-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise | 2018-06-14 | 2018-06-18 | 12,500 | — | $0 | 37,500 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2018-01-23 | 2018-01-25 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise deriv | 2017-06-14 | 2017-06-16 | 12,500 | — | $0 | 25,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise | 2017-06-14 | 2017-06-16 | 12,500 | — | $0 | 25,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2017-03-31 | 2017-04-04 | 12,500 | — | $0 | 12,500 | SEC↗ |